| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |